If you spend any time in the longevity and biohacking world right now, you have heard the claim: a Japanese enzyme called nattokinase can dissolve the plaque in your arteries. It is everywhere. Health podcasts, natural health platforms, supplement newsletters, all repeating the same headline number: a 36 percent reduction in arterial plaque. Search traffic for "nattokinase plaque" has exploded, and patients are showing up asking the same honest question. Is this real, or is it hype?

You deserve a straight answer from a cardiologist, not a supplement salesman. So here it is. The mechanism behind nattokinase is real and worth understanding. The viral study is real too, but it is nowhere near as strong as the headlines suggest. And the most important truth is the one nobody is repeating: an enzyme that clears fibrin does not fix the reason your body is building plaque and clots in the first place.

Let me walk you through it, and then let me show you where an enzyme honestly belongs in a 100 Year Heart.

What nattokinase actually is

Nattokinase is an enzyme originally identified in natto, a traditional Japanese food made from fermented soybeans. Its claim to fame is a single, specific job: it breaks down fibrin. Fibrin is the stringy, mesh-like protein your body uses to build a clot. Nattokinase is what we call a fibrinolytic agent, a fibrin dissolver. In the lab and in human blood, it measurably increases the breakdown of clots and nudges several clotting markers in a favorable direction. That part is not in dispute.

So the theory sounds elegant: if plaque and clots are held together by fibrin, and nattokinase breaks down fibrin, then nattokinase should clean out your arteries. Elegant, but incomplete. To see why, you have to understand what plaque actually is.

The root cause: fibrin, clotting, and endothelial injury

Here is the piece the headlines skip. Arterial plaque is not just cholesterol sludge sitting in a pipe. Plaque is an injury response. It begins when the delicate inner lining of your blood vessels, the endothelium and its protective glycocalyx coating, is damaged. That damage comes from the usual suspects: high blood sugar, oxidized fats from industrial seed oils, glyphosate and other toxins, high blood pressure, poor sleep, and chronic stress. Too much bad stuff. Not enough good stuff.

Once the endothelium is injured, your body does exactly what it was built to do at a wound. It clots. It lays down fibrin. It recruits inflammatory cells. Over years, that repeating cycle of injury and repair becomes plaque, and a body under constant assault drifts toward becoming hypercoagulable, too quick to clot. Fibrin is the scaffolding of that whole process.

Now you can see both the appeal and the limit of nattokinase. Working on fibrin is working downstream, on the scaffolding. It does nothing about the upstream injury that keeps the scaffolding going up. If your endothelium is under daily attack, you will keep forming clots and building plaque no matter how much fibrin you dissolve. Give the body what it needs; take away what it does not. An enzyme is not a substitute for that.

The viral study: impressive number, weak design

The 36 percent figure comes from a 2022 study published in Frontiers in Cardiovascular Medicine by Chen and colleagues (Chen et al., 2022; PMID 36072877). It followed 1,062 older adults who had high cholesterol and early carotid artery plaque. Those taking a high dose of nattokinase, 10,800 fibrinolytic units per day, for 12 months saw their carotid plaque size drop by an average of 36 percent, their artery wall thickness fall by about 22 percent, and their LDL cholesterol drop by roughly 18 percent. On paper, remarkable.

Two details matter before you get excited. First, dose. A lower dose of 3,600 units per day did essentially nothing: no meaningful change in lipids and no meaningful change in plaque. Whatever signal exists appears to depend on a high dose, far above the 2,000 unit amount many products carry. Second, and more important, this was not a rigorous trial. It was a single-arm, before-and-after look built from previously unanalyzed data, with no placebo group and no blinding. In plain terms, there was no comparison group of similar patients who did not take nattokinase. When you have no control group, you cannot rule out that other things, whether diet changes, other medications, or the simple fact that people in a study start taking better care of themselves, drove the results. A 36 percent number from a study designed like this is a signal worth investigating. It is not proof.

The rigorous trial nobody is quoting

Here is what the podcasts leave out. There is a gold-standard trial on nattokinase, and it was negative.

In 2021, Dr. Howard Hodis and his team at USC published the Nattokinase Atherothrombotic Prevention Study (Hodis et al., 2021; PMID 33843667). This was the design that actually tells you something: randomized, double-blinded, and placebo-controlled. They enrolled 265 healthy adults at low cardiovascular risk, gave them either nattokinase or an identical placebo, and tracked their carotid arteries with ultrasound for about three years. The result was a clean null. Compared with placebo, nattokinase produced no significant benefit on the progression of early atherosclerosis.

So which study is right? Both, actually, and they are not really in conflict once you line them up.

The two trials tested different doses, 10,800 units versus 2,000 units; in different people, older adults who already had plaque versus healthy, low-risk adults; using very different methods, a weak single-arm look versus a rigorous randomized trial. The honest reading is this: the mechanism is plausible, the high-dose signal in people who already have disease is intriguing, and the one time nattokinase was tested the right way, at a low dose in healthy people, it did nothing. The marketing is running well ahead of the evidence. You do not have a nattokinase deficiency.

So where does an enzyme actually belong?

If I am this honest about the evidence, you might expect me to tell you to skip enzymes entirely. I will not, because that would be as lazy as the hype. Used correctly, as a tool inside the 100 Year Heart Method and not as a miracle bottle on its own, enzymes that support your body’s own circulation and fibrin balance earn a place. That is exactly why we formulated Flow.

What Flow is

Flow is a two-enzyme formula. It combines a nattokinase-type fibrinolytic enzyme, Nattozimes, with a serrapeptase-type enzyme, Serrazimes. Both are plant and fungal sourced, which is why Flow is gluten-free, soy-free, dairy-free, and non-GMO, in a veggie capsule with no fillers.

Here is what each one does in plain terms. The fibrinolytic enzyme supports your body’s own ability to break down fibrin, the mesh that forms the scaffolding of a clot. The serrapeptase-type enzyme supports a healthy, balanced inflammatory response and helps your body manage the excess proteins that drive stiffness and congestion. Together, the intended job is simple: support healthy circulation, support a normal fibrin balance, and support a calm inflammatory tone in your vessels and beyond. Notice the word. Support. It nudges normal physiology in the right direction. It does not override disease.

A word on potency, because it is a fair question. Most nattokinase capsules on the shelf deliver around 2,000 fibrinolytic units, the low end of what has been used in the research. Flow is built stronger than that. Each capsule provides 4,516 fibrinolytic units of nattokinase-type enzyme activity, so the twice-daily serving delivers 9,032 units of fibrinolytic support for your body’s own clot-clearing system, well above the typical single-enzyme product. And Flow does something a stand-alone nattokinase capsule cannot: each capsule also carries 20,000 units of Serrazimes, a serrapeptase-type enzyme that works on inflammatory balance. A high-potency fibrinolytic dose plus a second enzyme in one capsule is the reason we built our own formula instead of pointing you to any bottle on the shelf.

Where Flow fits in the Method

Everything at Natural Heart Doctor runs through six pillars: Eat Well, Live Well, Think Well, Test Don’t Guess, Evidence-Based Supplements, and BioHacking. Flow lives in the supplement pillar, and the order matters. Real food, sunlight, movement, sleep, and stress work come first. Testing tells you what your body is actually doing. Only then does a targeted supplement like Flow make sense, as one tool that supports healthy circulation while you do the upstream work that actually changes your trajectory.

Pharma last, not first. And to be clear, an enzyme is not first either. You are the hero of this story. Flow is a guide’s tool, nothing more.

Honest expectations and how to take it

Let me set expectations plainly, because most product pages will not. Flow is designed to support healthy circulation and a normal inflammatory and fibrin balance. It is not designed to break down existing plaque, thin your blood like a drug, lower a diagnosed high blood pressure, or replace anything your physician has prescribed. Anyone promising you that from a capsule is selling, not teaching.

Used consistently, as part of a real plan, many people simply feel better: lighter legs, warmer hands and feet, easier breathing, less day-to-day stiffness. Those are quality-of-life wins worth having, and they are exactly what you would expect from an enzyme that supports normal circulation and inflammatory balance. The standard serving is one capsule twice a day, on an empty stomach, one in the morning and one before bed, taken consistently over time.

If you want to go further, some people step up to a higher serving: one capsule three times a day, each dose taken away from food. Because Flow works on your body’s own clot-breakdown processes, that is a decision to make with our team rather than on your own, so we can factor in your medications, your history, and your test results. More is not automatically better with a fibrinolytic enzyme. The right serving is the one matched to you.

Who should use caution

This matters more with Flow than with most supplements, so read it carefully. Because Flow supports your body’s clot-breakdown processes, it can affect bleeding and clotting. Do not start Flow on your own if any of the following apply to you:

• You take a prescription blood thinner or antiplatelet medication
• You have a bleeding or clotting disorder
• You are pregnant or nursing
• You have surgery, a procedure, or dental work coming up

In every one of those situations, this is a conversation to have with a physician who knows your full picture, not a decision to make from a product page. Protecting you is part of the job.

Test, don’t guess

Here is the root-cause move most people skip. Your clotting tendency and your inflammation are measurable. Before you decide whether an enzyme like Flow even makes sense for you, find out where you actually stand. A handful of markers tell the real story:

• Fibrinogen, and in the right context D-dimer, for how primed your blood is to clot
• hs-CRP, a window into vascular inflammation
• Lipoprotein(a) and ApoB, inherited and particle-based risk that standard panels miss
• Homocysteine, a driver of endothelial injury and clotting
• Lipid peroxides, the upstream oxidative-damage signal

Those numbers turn a guessing game into a plan. If you are hypercoagulable and inflamed, the answer is not simply an enzyme; it is finding and removing what is injuring your endothelium, then rebuilding it with real food, sunlight, movement, sleep, and stress work. Eat Well. Live Well. Think Well. Then add the right tool if it fits.

The bottom line

Nattokinase is a real enzyme with a real mechanism and a genuinely interesting high-dose signal, riding on top of a viral study that cannot prove cause and effect, and shadowed by a rigorous trial that found nothing. The number is not the root cause. Plaque is an injury story, and clearing fibrin downstream will never replace protecting the endothelium upstream. Flow can support healthy circulation as one honest tool in your plan, but the plan is what protects your heart.

So before you chase a 36% headline, find out what your arteries are actually doing. Order a clotting and inflammation panel and see whether your blood is running hot; no doctor’s order, referral, or prescription required, and our team helps you arrange the draw at a lab near you. Or book a free discovery call with the Natural Heart Doctor team, and let us build your plan around root causes, not headlines.

Cheers to Your 100 Year Heart.

Dr. Jack Wolfson
Cardiologist since 2002. Founder of Natural Heart Doctor